A combination of MTAP and BAP1 immunohistochemistry in pleural effusion cytology for the diagnosis of mesothelioma.
Yoshiaki KinoshitaTomoyuki HidaMakoto HamasakiShinji MatsumotoAyuko SatoTohru TsujimuraKunimitsu KawaharaKenzo HiroshimaYoshinao OdaKazuki NabeshimaPublished in: Cancer cytopathology (2017)
A combination of MTAP and BAP1 IHC in cell blocks from pleural effusions appears to be a reliable and useful method for differentiating MPM cells from RMC and can be used in the routine diagnosis of MPM. Cancer Cytopathol 2018;126:54-63. © 2017 American Cancer Society.